Callan JMB (NASDAQ:CJMB) Upgraded to Hold at Wall Street Zen

Callan JMB (NASDAQ:CJMBGet Free Report) was upgraded by Wall Street Zen to a “hold” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Callan JMB in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, Callan JMB presently has an average rating of “Sell”.

Read Our Latest Analysis on Callan JMB

Callan JMB Stock Down 29.3%

CJMB stock opened at $1.28 on Friday. The company’s 50-day moving average price is $1.89 and its two-hundred day moving average price is $2.75. The firm has a market cap of $5.91 million and a P/E ratio of -1.03. Callan JMB has a 12 month low of $1.08 and a 12 month high of $5.88.

Insider Transactions at Callan JMB

In other Callan JMB news, insider David J. Croyle bought 14,805 shares of the stock in a transaction on Friday, March 6th. The stock was purchased at an average price of $1.76 per share, with a total value of $26,056.80. Following the completion of the purchase, the insider owned 789,805 shares in the company, valued at $1,390,056.80. The trade was a 1.91% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 73.87% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Callan JMB

An institutional investor recently raised its position in Callan JMB stock. Creative Planning lifted its stake in shares of Callan JMB Inc. (NASDAQ:CJMBFree Report) by 41.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 170,008 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Creative Planning owned 3.79% of Callan JMB worth $830,000 as of its most recent filing with the Securities and Exchange Commission.

About Callan JMB

(Get Free Report)

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.

Featured Stories

Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.